Form 8-K - Current report:
SEC Accession No. 0001731122-25-001173
Filing Date
2025-08-26
Accepted
2025-08-26 16:45:53
Documents
14
Period of Report
2025-08-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e6800_8k.htm   iXBRL 8-K 27220
2 EXHIBIT 3.1 e6800_ex3-1.htm EX-3.1 9230
3 GRAPHIC image_007.gif GRAPHIC 1241
  Complete submission text file 0001731122-25-001173.txt   207197

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE renb-20250826.xsd EX-101.SCH 3029
5 XBRL LABEL FILE renb-20250826_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE renb-20250826_pre.xml EX-101.PRE 22368
16 EXTRACTED XBRL INSTANCE DOCUMENT e6800_8k_htm.xml XML 3800
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 251258309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)